Global and United States Human Microbiome Therapeutics Market Size, Status and Forecast 2021-2027

Global and United States Human Microbiome Therapeutics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Microbiome Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 FMT
1.2.3 Microbiome Drugs
1.3 Market by Application
1.3.1 Global Human Microbiome Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 C. difficile
1.3.3 Crohn's Disease
1.3.4 Inflammatory Bowel Disease
1.3.5 Diabetes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Human Microbiome Therapeutics Market Perspective (2016-2027)
2.2 Human Microbiome Therapeutics Growth Trends by Regions
2.2.1 Human Microbiome Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Human Microbiome Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Human Microbiome Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Human Microbiome Therapeutics Industry Dynamic
2.3.1 Human Microbiome Therapeutics Market Trends
2.3.2 Human Microbiome Therapeutics Market Drivers
2.3.3 Human Microbiome Therapeutics Market Challenges
2.3.4 Human Microbiome Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Microbiome Therapeutics Players by Revenue
3.1.1 Global Top Human Microbiome Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Human Microbiome Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Human Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Human Microbiome Therapeutics Revenue
3.4 Global Human Microbiome Therapeutics Market Concentration Ratio
3.4.1 Global Human Microbiome Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Therapeutics Revenue in 2020
3.5 Human Microbiome Therapeutics Key Players Head office and Area Served
3.6 Key Players Human Microbiome Therapeutics Product Solution and Service
3.7 Date of Enter into Human Microbiome Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Microbiome Therapeutics Breakdown Data by Type
4.1 Global Human Microbiome Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Human Microbiome Therapeutics Forecasted Market Size by Type (2022-2027)
5 Human Microbiome Therapeutics Breakdown Data by Application
5.1 Global Human Microbiome Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Human Microbiome Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Human Microbiome Therapeutics Market Size (2016-2027)
6.2 North America Human Microbiome Therapeutics Market Size by Type
6.2.1 North America Human Microbiome Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Human Microbiome Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Human Microbiome Therapeutics Market Size by Type (2016-2027)
6.3 North America Human Microbiome Therapeutics Market Size by Application
6.3.1 North America Human Microbiome Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Human Microbiome Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Human Microbiome Therapeutics Market Size by Application (2016-2027)
6.4 North America Human Microbiome Therapeutics Market Size by Country
6.4.1 North America Human Microbiome Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Human Microbiome Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Human Microbiome Therapeutics Market Size (2016-2027)
7.2 Europe Human Microbiome Therapeutics Market Size by Type
7.2.1 Europe Human Microbiome Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Human Microbiome Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Human Microbiome Therapeutics Market Size by Type (2016-2027)
7.3 Europe Human Microbiome Therapeutics Market Size by Application
7.3.1 Europe Human Microbiome Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Human Microbiome Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Human Microbiome Therapeutics Market Size by Application (2016-2027)
7.4 Europe Human Microbiome Therapeutics Market Size by Country
7.4.1 Europe Human Microbiome Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Human Microbiome Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Human Microbiome Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Human Microbiome Therapeutics Market Size by Type
8.2.1 Asia-Pacific Human Microbiome Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Human Microbiome Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Human Microbiome Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Human Microbiome Therapeutics Market Size by Application
8.3.1 Asia-Pacific Human Microbiome Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Human Microbiome Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Human Microbiome Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Human Microbiome Therapeutics Market Size by Region
8.4.1 Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Human Microbiome Therapeutics Market Size (2016-2027)
9.2 Latin America Human Microbiome Therapeutics Market Size by Type
9.2.1 Latin America Human Microbiome Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Human Microbiome Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Human Microbiome Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Human Microbiome Therapeutics Market Size by Application
9.3.1 Latin America Human Microbiome Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Human Microbiome Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Human Microbiome Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Human Microbiome Therapeutics Market Size by Country
9.4.1 Latin America Human Microbiome Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Human Microbiome Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Microbiome Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Human Microbiome Therapeutics Market Size by Type
10.2.1 Middle East & Africa Human Microbiome Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Human Microbiome Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Human Microbiome Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Human Microbiome Therapeutics Market Size by Application
10.3.1 Middle East & Africa Human Microbiome Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Human Microbiome Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Human Microbiome Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Human Microbiome Therapeutics Market Size by Country
10.4.1 Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Enterome Bioscience
11.1.1 Enterome Bioscience Company Details
11.1.2 Enterome Bioscience Business Overview
11.1.3 Enterome Bioscience Human Microbiome Therapeutics Introduction
11.1.4 Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2016-2021)
11.1.5 Enterome Bioscience Recent Development
11.2 Rebiotix
11.2.1 Rebiotix Company Details
11.2.2 Rebiotix Business Overview
11.2.3 Rebiotix Human Microbiome Therapeutics Introduction
11.2.4 Rebiotix Revenue in Human Microbiome Therapeutics Business (2016-2021)
11.2.5 Rebiotix Recent Development
11.3 Seres Therapeutics
11.3.1 Seres Therapeutics Company Details
11.3.2 Seres Therapeutics Business Overview
11.3.3 Seres Therapeutics Human Microbiome Therapeutics Introduction
11.3.4 Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2016-2021)
11.3.5 Seres Therapeutics Recent Development
11.4 Vedanta Biosciences
11.4.1 Vedanta Biosciences Company Details
11.4.2 Vedanta Biosciences Business Overview
11.4.3 Vedanta Biosciences Human Microbiome Therapeutics Introduction
11.4.4 Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2016-2021)
11.4.5 Vedanta Biosciences Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Human Microbiome Therapeutics Introduction
11.5.4 Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Human Microbiome Therapeutics Introduction
11.6.4 Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Details
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Human Microbiome Therapeutics Introduction
11.7.4 Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2016-2021)
11.7.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Human Microbiome Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of FMT
Table 3. Key Players of Microbiome Drugs
Table 4. Global Human Microbiome Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Human Microbiome Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Human Microbiome Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Human Microbiome Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Human Microbiome Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Human Microbiome Therapeutics Market Share by Regions (2022-2027)
Table 10. Human Microbiome Therapeutics Market Trends
Table 11. Human Microbiome Therapeutics Market Drivers
Table 12. Human Microbiome Therapeutics Market Challenges
Table 13. Human Microbiome Therapeutics Market Restraints
Table 14. Global Human Microbiome Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Human Microbiome Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Human Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome Therapeutics as of 2020)
Table 17. Ranking of Global Top Human Microbiome Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Human Microbiome Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human Microbiome Therapeutics Product Solution and Service
Table 21. Date of Enter into Human Microbiome Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Human Microbiome Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Human Microbiome Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Human Microbiome Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Human Microbiome Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Human Microbiome Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Human Microbiome Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Human Microbiome Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Human Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Human Microbiome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Human Microbiome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Human Microbiome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Human Microbiome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Human Microbiome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Human Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Human Microbiome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Human Microbiome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Human Microbiome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Human Microbiome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Human Microbiome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Human Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Human Microbiome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Human Microbiome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Human Microbiome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Human Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Human Microbiome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Human Microbiome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Human Microbiome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Human Microbiome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Human Microbiome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Human Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Human Microbiome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Human Microbiome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Human Microbiome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Enterome Bioscience Company Details
Table 62. Enterome Bioscience Business Overview
Table 63. Enterome Bioscience Human Microbiome Therapeutics Product
Table 64. Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Enterome Bioscience Recent Development
Table 66. Rebiotix Company Details
Table 67. Rebiotix Business Overview
Table 68. Rebiotix Human Microbiome Therapeutics Product
Table 69. Rebiotix Revenue in Human Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Rebiotix Recent Development
Table 71. Seres Therapeutics Company Details
Table 72. Seres Therapeutics Business Overview
Table 73. Seres Therapeutics Human Microbiome Therapeutics Product
Table 74. Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Seres Therapeutics Recent Development
Table 76. Vedanta Biosciences Company Details
Table 77. Vedanta Biosciences Business Overview
Table 78. Vedanta Biosciences Human Microbiome Therapeutics Product
Table 79. Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Vedanta Biosciences Recent Development
Table 81. Bristol-Myers Squibb Company Details
Table 82. Bristol-Myers Squibb Business Overview
Table 83. Bristol-Myers Squibb Human Microbiome Therapeutics Product
Table 84. Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Bristol-Myers Squibb Recent Development
Table 86. Johnson & Johnson Company Details
Table 87. Johnson & Johnson Business Overview
Table 88. Johnson & Johnson Human Microbiome Therapeutics Product
Table 89. Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Johnson & Johnson Recent Development
Table 91. Takeda Pharmaceutical Company Details
Table 92. Takeda Pharmaceutical Business Overview
Table 93. Takeda Pharmaceutical Human Microbiome Therapeutics Product
Table 94. Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Takeda Pharmaceutical Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Microbiome Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. FMT Features
Figure 3. Microbiome Drugs Features
Figure 4. Global Human Microbiome Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. C. difficile Case Studies
Figure 6. Crohn's Disease Case Studies
Figure 7. Inflammatory Bowel Disease Case Studies
Figure 8. Diabetes Case Studies
Figure 9. Others Case Studies
Figure 10. Human Microbiome Therapeutics Report Years Considered
Figure 11. Global Human Microbiome Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Human Microbiome Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Human Microbiome Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Human Microbiome Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Human Microbiome Therapeutics Market Share by Players in 2020
Figure 16. Global Top Human Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Human Microbiome Therapeutics Revenue in 2020
Figure 18. Global Human Microbiome Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Human Microbiome Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Human Microbiome Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Human Microbiome Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Human Microbiome Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Human Microbiome Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Human Microbiome Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Human Microbiome Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Human Microbiome Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Human Microbiome Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Human Microbiome Therapeutics Market Share by Region (2016-2027)
Figure 40. China Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Human Microbiome Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Human Microbiome Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Human Microbiome Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Human Microbiome Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Human Microbiome Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Human Microbiome Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Enterome Bioscience Revenue Growth Rate in Human Microbiome Therapeutics Business (2016-2021)
Figure 60. Rebiotix Revenue Growth Rate in Human Microbiome Therapeutics Business (2016-2021)
Figure 61. Seres Therapeutics Revenue Growth Rate in Human Microbiome Therapeutics Business (2016-2021)
Figure 62. Vedanta Biosciences Revenue Growth Rate in Human Microbiome Therapeutics Business (2016-2021)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Human Microbiome Therapeutics Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Human Microbiome Therapeutics Business (2016-2021)
Figure 65. Takeda Pharmaceutical Revenue Growth Rate in Human Microbiome Therapeutics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Thyroid Gland Disorders Treatment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 80

Thyroid Gland Disorder Treatment is a kind of treatment method, which aims to The thyroid disorder patients, such as hypothyroidism patients and hyperthyroidism patients. When The thyroid gland does not produce sufficient hypothyroidism or too much hyperthyroidism, The body metabolism and functioning will be disrupted. The global Thyroid Gland Disorders Treatment market was valued at US$ 2950 million in 2023 and is anticipated to reach US$ 3871.9 million by 2030, witnessing a CAGR o......

Global Brachytherapy Afterloaders, Brachytherapy Seeds Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98

According to our LPI (LP Information) latest study, the global Brachytherapy Afterloaders, Brachytherapy Seeds market size was valued at US$ 150.8 million in 2023. With growing demand in downstream market, the Brachytherapy Afterloaders, Brachytherapy Seeds is forecast to a readjusted size of US$ 168.1 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Brachytherapy Afterloaders, Brachytherapy Seeds market. Brachyth......

Global Peptide Therapeutics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Peptide Therapeutics market size was valued at US$ 33800 million in 2023. With growing demand in downstream market, the Peptide Therapeutics is forecast to a readjusted size of US$ 63130 million by 2030 with a CAGR of 9.3% during review period. The research report highlights the growth potential of the global Peptide Therapeutics market. Peptide Therapeutics are expected to show stable growth in the future market. However, pr......

Global Microbiome Therapeutics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Microbiome Therapeutics market size was valued at US$ 89 million in 2023. With growing demand in downstream market, the Microbiome Therapeutics is forecast to a readjusted size of US$ 916.3 million by 2030 with a CAGR of 39.5% during review period. The research report highlights the growth potential of the global Microbiome Therapeutics market. Microbiome Therapeutics are expected to show stable growth in the future market. H......

Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Anti-inflammatory Therapeutics market size was valued at US$ 108140 million in 2023. With growing demand in downstream market, the Anti-inflammatory Therapeutics is forecast to a readjusted size of US$ 166150 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Anti-inflammatory Therapeutics market. Anti-inflammatory Therapeutics are expected to show stabl......

Global Enzyme Replacement Therapy Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 113

According to our LPI (LP Information) latest study, the global Enzyme Replacement Therapy market size was valued at US$ 11570 million in 2023. With growing demand in downstream market, the Enzyme Replacement Therapy is forecast to a readjusted size of US$ 29900 million by 2030 with a CAGR of 14.5% during review period. The research report highlights the growth potential of the global Enzyme Replacement Therapy market. Enzyme Replacement Therapy are expected to show stable growth in the f......

Global Infantile Spasms Therapeutics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 84

According to our LPI (LP Information) latest study, the global Infantile Spasms Therapeutics market size was valued at US$ 138.9 million in 2023. With growing demand in downstream market, the Infantile Spasms Therapeutics is forecast to a readjusted size of US$ 179.6 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Infantile Spasms Therapeutics market. Infantile Spasms Therapeutics are expected to show stable grow......

Global Hormone Replacement Therapy Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128

According to our LPI (LP Information) latest study, the global Hormone Replacement Therapy market size was valued at US$ 16090 million in 2023. With growing demand in downstream market, the Hormone Replacement Therapy is forecast to a readjusted size of US$ 17930 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Hormone Replacement Therapy market. Hormone Replacement Therapy are expected to show stable growth in th......

Global Plasma Therapy Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107

According to our LPI (LP Information) latest study, the global Plasma Therapy market size was valued at US$ 265.3 million in 2023. With growing demand in downstream market, the Plasma Therapy is forecast to a readjusted size of US$ 529.4 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Plasma Therapy market. Plasma Therapy are expected to show stable growth in the future market. However, product differentiation, ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs